Form 4 for ZVRA ZEVRA THERAPEUTICS, INC.
Accepted 2026-03-26 00:00:00 ET · period of report 2026-03-24 · accession 0001612084-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-26 | 2026-03-24 | ZVRA | Bode John B | Dir | M - OptEx | $4.93 | +78.4K | 123.4K | +174% | +$386.5K |
| DM | 2026-03-26 | 2026-03-24 | ZVRA | Bode John B | Dir | M - OptEx | $0.00 | -78.4K | 19.6K | -80% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-24 | M | A | 39,200 | $4.97 | 84,200 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-24 | M | A | 39,200 | $4.89 | 123,400 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2026-03-24 | M | D | 39,200 | $0.00 | 0 | D | $4.89 · — to 2034-05-12 | 39,200 Common Stock | (F2) The shares underlying this option, which was granted on May 13, 2024, were fully vested. |
| 4 | Derivative | Stock Option (right to buy) | 2026-03-24 | M | D | 39,200 | $0.00 | 19,600 | D | $4.97 · — to 2033-05-02 | 39,200 Common Stock | (F1) The remaining shares underlying this option, which was granted on May 3, 2023, will vest one day prior to the date of the third annual meeting of the Issuer's stockholders following the day of the grant, subject to the Reporting Person's continued service as a director. |